5-(4-(Dimethylamino)benzylidene)-2-(4-ethoxyphenyl)thiazolo[3,2-b][1,2,4]triazol-6(5H)-one

Catalog No. :
ACGUWO355
CAS No. :
538340-05-5
Molecular Formula :
C21H20N4O2S
Molecular Weight :
392.48

IUPAC Name:(Z)-5-(4-(dimethylamino)benzylidene)-2-(4-ethoxyphenyl)thiazolo[3,2-b][1,2,4]triazol-6(5H)-one

5-(4-(Dimethylamino)benzylidene)-2-(4-ethoxyphenyl)thiazolo[3,2-b][1,2,4]triazol-6(5H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(4-(Dimethylamino)benzylidene)-2-(4-ethoxyphenyl)thiazolo[3,2-b][1,2,4]triazol-6(5H)-one
IUPAC Name(Z)-5-(4-(dimethylamino)benzylidene)-2-(4-ethoxyphenyl)thiazolo[3,2-b][1,2,4]triazol-6(5H)-one
Molecular FormulaC21H20N4O2S
Molecular Weight392.48
SMILESO=C(N1N=C(C2=CC=C(OCC)C=C2)N=C1S/3)C3=C\C4=CC=C(N(C)C)C=C4
InChI KeyJXHCOLNLYGREAJ-AQTBWJFISA-N
Synonym(5Z)-5-[[4-(dimethylamino)phenyl]methylidene]-2-(4-ethoxyphenyl)-[1,3]thiazolo[3,2-b][1,2,4]triazol-6-one;SALOR-INT L436755-1EA;(5Z)-5-[4-(DIMETHYLAMINO)BENZYLIDENE]-2-(4-ETHOXYPHENYL)[1,3]THIAZOLO[3,2-B][1,2,4]TRIAZOL-6(5H)-ONE;Thiazolo[3,2-b][1,2,4]triazol-6(5H)-one, 5-[[4-(dimethylamino)phenyl]methylene]-2-(4-ethoxyphenyl)-
CAS No.538340-05-5

Synthetic Route by SureRoute

1. ACGUWO355 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGUWO355 route product structure diagram
    ACGUWO355538340-05-5
Inquiry

2. ACGUWO355 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBNPV839 route compound structure diagram
    ACBNPV839100-10-7 In Stock
  4. Then
  5. ACGUWO355 route product structure diagram
    ACGUWO355538340-05-5
Inquiry

Comments (0)